RECURSION PHARMACEUTICALS, INC. Quarterly Interest Expense in USD from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Recursion Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2020 to Q1 2024.
  • Recursion Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $20K, a 5.26% increase year-over-year.
  • Recursion Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $98K, a 63.3% increase year-over-year.
  • Recursion Pharmaceuticals, Inc. annual Interest Expense for 2023 was $97K, a 76.4% increase from 2022.
  • Recursion Pharmaceuticals, Inc. annual Interest Expense for 2022 was $55K, a 98.1% decline from 2021.
  • Recursion Pharmaceuticals, Inc. annual Interest Expense for 2021 was $2.95M, a 117% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $98K $20K +$1K +5.26% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $97K $27K +$13K +92.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $84K $25K +$12K +92.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $72K $26K +$12K +85.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $60K $19K +$5K +35.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $55K $14K +$32K Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $23K $13K -$207K -94.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $230K $14K -$2.49M -99.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $2.72M $14K -$235K -94.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $2.95M -$18K Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $220K -$181K -45.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $2.5M +$2.08M +487% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $249K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $401K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $426K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.